1. Adekunle, O.O. (2012). Mechanisms of Antimicrobial Resistance in Bacteria in southwestern Nigeria, General Approach International Journal of Pharmacy, Medicine and Biological Science, 1(2),166-183
2. Ahmed, S., Parvin, S., Shaha, D., Begum, P., Sanjowal, L., Hassan, M. K. and Mohammad Arif, K. (2017). Clinical Profile of Pelvic Inflammatory Disease (PID). Faridpur Medical College Journal, 12(1): 25-30.https://doi.org/10.3329/fmcj.v12i1.33487
3. Centers for Disease Control and Prevention (2015). sexually transmitted diseases treatment guidelines. Pelvic inflammatory disease (PID). Retrieved May 25th, 2018 from, http://www.cdc.gov/std/tg2015/pid.htm
4. Cheesbrough, M. (2010). District Laboratory Practicein Tropical Countries, Part 2, 2nd Edition update. United Kingdom: Cambridge University Press, Cambridge, Pp 107-114.
5. Clinical and laboratory standards institute (2016). Performance standards for antimicrobial susceptibility testing.26th Edition. Supplement M100S. CLSI, Wayne,Pages: 224